RxDoctor Payments Data

Manamar Singh, MD

Internal Medicine · Chicago, ILNPI 1770899221

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 15th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$716,188
Medicare patients
1,422
Services billed
6,277

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban413$146,852
NuplazidPimavanserin Tartrate23$57,169
JardianceEmpagliflozin75$39,068
EntrestoSacubitril/Valsartan60$29,952
XareltoRivaroxaban76$24,389
MyrbetriqMirabegron55$20,387
JanuviaSitagliptin Phosphate53$20,246
Memantine Hcl328$15,106
Daptomycin21$13,197
OzempicSemaglutide11$11,461
NeuproRotigotine26$10,922
Atorvastatin Calcium639$10,045
Fluticasone-SalmeterolFluticasone Propion/Salmeterol46$9,046
Breo ElliptaFluticasone/Vilanterol18$7,770
Spiriva HandihalerTiotropium Bromide14$7,643

Paid to pharmacies, not to this prescriber.

Other internal medicine in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →